Smith & Nephew PLC (SNN) shares tumbled 5.54% in pre-market trading, driven by a pronounced sell-side order imbalance on the New York Stock Exchange.
The NYSE reported a sell-side imbalance of 41,040 shares for SNN, meaning sell orders significantly outweighed buy orders. This exerted heavy downward pressure on the stock, with no other company-specific developments or broader market catalysts surfacing to account for the move.
The medical device maker’s pre-market plunge reflects the weight of the order imbalance as sellers dominated the session.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments